Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010 | Zendy

Shiona K Glass-Kaastra | Zendy; Rita Finley | Zendy; Jim Hutchinson | Zendy; David M. Patrick | Zendy; Karl Heinz Weiss | Zendy; John Conly | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010

Author(s) -

Shiona K Glass-Kaastra,

Rita Finley,

Jim Hutchinson,

David M. Patrick,

Karl Heinz Weiss,

John Conly

Publication year - 2014

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2014/537948

Subject(s) - antimicrobial , penicillin , cephalosporin , medicine , medical prescription , antibiotic resistance , population , defined daily dose , environmental health , antibiotics , microbiology and biotechnology , biology , pharmacology

β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resistance, monitoring the volume and patterns of use of these agents is highly important.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research